Invivo Partners

Invivo Partners is a Spanish venture capital firm co-founded by Dr. Luis Pareras and Albert Ferrer. The firm invests in early-stage life science companies at the intersection of advanced therapies, synthetic biology, and artificial intelligence. It has managed two funds supported by a majority of private investors and a number of institutional investors such as the European Investment Fund (EIF), Fond-ICO Global, the Catalan Finance Institute, the Valencia Institute of Finance, and the Barcelona City Council.

Invivo Partners is headquartered in Barcelona, Spain and is committed to driving meaningful change and progress in the healthcare sector. The firm's track record of successful investments and its strategic focus on areas like synthetic biology and advanced therapies underline its dedication to catalyzing life science breakthroughs.

The company has got two successful exits from the firm's first fund in 2022, validating its early-stage investment thesis focused on extraordinary science in leading-edge fields that are to play a role in the future of medicine.

The portfolio companies from the first fund have raised >220M€ from international VCs. Initial investments range from 2-4M€, with follow-ons in portfolio companies up to 10M€ per company after meeting set milestones. Europe is the geographical focus, being Spain the main target.